Related Experiment Video
Updated: Aug 10, 2025
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
13.2K
The Japan Glaucoma Society guidelines for glaucoma 5th edition
Yoshiaki Kiuchi1, Toshihiro Inoue2, Nobuyuki Shoji3
1Department of Ophthalmology and Visual Science, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-31 Kasumi, Minami-ku, Hiroshima, Japan. ykiuchi@hiroshima-u.ac.jp.
Japanese Journal of Ophthalmology
|February 13, 2023
Summary
The 5th edition of Glaucoma Clinical Practice Guidelines offers evidence-based treatment recommendations for glaucoma, a complex syndrome. This update focuses on lowering intraocular pressure through drugs, lasers, and surgery.
Area of Science:
- Ophthalmology
- Clinical Practice Guidelines
Background:
- The 5th edition of the Glaucoma Clinical Practice Guidelines is now available.
- First published in 2003, these guidelines represent the first for glaucoma treatment in Japan.
Discussion:
- Glaucoma management requires a comprehensive approach, considering it a complex syndrome rather than a single entity.
- Treatment modalities include pharmacotherapy, laser procedures, and surgical interventions aimed at reducing intraocular pressure.
Key Insights:
- The core principle of glaucoma treatment is the reduction of intraocular pressure.
- The guidelines emphasize that effective glaucoma treatment is multifaceted and not a one-size-fits-all approach.
Outlook:
- This edition incorporates a Clinical Questionnaire to refine glaucoma treatment strategies.
- The updated guidelines aim to provide the most appropriate and evidence-based care for glaucoma patients.
Related Concept Videos
01:25Glaucoma: Overview
672
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
672
01:27Open Angle Glaucoma: Treatment
516
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
516
01:28Angle Closure Glaucoma: Treatment
604
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
604
01:26Nephrotic Syndrome II : Assessment and Medical Management
14
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
14
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
36
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
36